Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: Contrast with haloperidol and chlordiazepoxide

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 4, 2008, Pages 551-562

  Mead, Alexa ^a   Li, Ming ^a   Kapur, Shitij ^b,c  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chlordiazepoxide; Clozapine; Conditioned avoidance response; Conditioned place aversion; Haloperidol; Passive avoidance; Ultrasonic vocalizations

Indexed keywords

CHLORDIAZEPOXIDE; CLOZAPINE; HALOPERIDOL; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DEFECATION; FEAR; HABITUATION; HYPERTHERMIC THERAPY; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; VOCALIZATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BENZODIAZEPINES; CHLORDIAZEPOXIDE; CLOZAPINE; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; HALOPERIDOL; HYPNOTICS AND SEDATIVES; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; VOCALIZATION, ANIMAL;

EID: 48749126204     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.04.014     Document Type: Article

References (77)

1. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106 (1999) 119-125
2. Allen C., Allen B.S., and Rake A.V. Pharmacological distinctions between "active" and "passive" avoidance memory formation as shown by manipulation of biogenic amine active compounds. Psychopharmacologia 34 (1974) 1-10
3. Amorapanth P., LeDoux J.E., and Nader K. Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat Neurosci 3 (2000) 74-79
4. Anisman H., Irwin J., Zacharko R.M., and Tombaugh T.N. Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue-shock and response-outcome associations. Behav Neural Biol 36 (1982) 280-290
5. Antoniadis E.A., and McDonald R.J. Discriminative fear conditioning to context expressed by multiple measures of fear in the rat. Behav Brain Res 101 (1999) 1-13
6. Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol (Copenh) 51 (1982) 321-329
7. Bartoszyk G.D. Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. Life Sci 62 (1998) 649-663
8. Beninger R.J., Mason S.T., Phillips A.G., and Fibiger H.C. The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J Pharmacol Exp Ther 213 (1980) 623-627
9. Bhana N., Foster R.H., Olney R., and Plosker G.L. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 61 (2001) 111-161
10. Bitran D., Klibansky D.A., and Martin G.A. The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology (Berl) 151 (2000) 31-37
11. Brooke N.S., Wiersgalla M., and Salzman C. Atypical uses of atypical antipsychotics. Harv Rev Psychiatry 13 (2005) 317-339
12. Brot M.D., Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 325 (1997) 1-7
13. Bruhwyler J., Chleide E., Liegeois J.F., Delarge J., and Mercier M. Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test. Pharmacol Biochem Behav 36 (1990) 57-61
14. Bruhwyler J., Chleide E., and Mercier M. Clozapine: an atypical neuroleptic. Neurosci Biobehav Rev 14 (1990) 357-363
15. Burgdorf J., Knutson B., Panksepp J., and Shippenberg T.S. Evaluation of rat ultrasonic vocalizations as predictors of the conditioned aversive effects of drugs. Psychopharmacology (Berl) 155 (2001) 35-42
16. Cao B.J., and Rodgers R.J. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze. Eur J Pharmacol 335 (1997) 117-125
17. Carson W.H., Kitagawa H., and Nemeroff C.B. Drug development for anxiety disorders: new roles for atypical antipsychotics. Psychopharmacol Bull 38 Suppl 1 (2004) 38-45
18. Decker M.W., Tran T., and McGaugh J.L. A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice. Psychopharmacology (Berl) 100 (1990) 515-521
19. Di Scala G., and Sandner G. Conditioned place aversion produced by FG 7142 is attenuated by haloperidol. Psychopharmacology (Berl) 99 (1989) 176-180
20. De Vry J., Benz U., Schreiber R., and Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 249 (1993) 331-339
21. Fang J.C., Hinrichs J.V., and Ghoneim M.M. Diazepam and memory: evidence for spared memory function. Pharmacol Biochem Behav 28 (1987) 347-352
22. Fanselow M.S. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann N Y Acad Sci 467 (1986) 40-54
23. Fernandez-Tome M.P., Sanchez-Blazquez P., and del Rio J. Impairment by apomorphine of one-trial passive avoidance learning in mice: the opposing roles of the dopamine and noradrenaline systems. Psychopharmacology (Berl) 61 (1979) 43-47
24. Frye C.A., and Seliga A.M. Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats. Psychoneuroendocrinology 28 (2003) 657-673
25. Godsil B.P., Quinn J.J., and Fanselow M.S. Body temperature as a conditional response measure for Pavlovian fear conditioning. Learn Mem 7 (2000) 353-356
26. Greba Q., Gifkins A., and Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res 899 (2001) 218-226
27. Guarraci F.A., Frohardt R.J., Falls W.A., and Kapp B.S. The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav Neurosci 114 (2000) 647-651
28. Holahan M.R., and White N.M. Intra-amygdala muscimol injections impair freezing and place avoidance in aversive contextual conditioning. Learn Mem 11 (2004) 436-446
29. Ichihara K., Nabeshima T., and Kameyama T. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur J Pharmacol 151 (1988) 435-442
30. Inoue T., Tsuchiya K., and Koyama T. Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear. Pharmacol Biochem Behav 55 (1996) 195-201
31. Inoue T., Izumi T., Li X.B., Kitaichi Y., Nakagawa S., and Koyama T. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear. Eur J Pharmacol 519 (2005) 253-258
32. Ishida-Tokuda K., Ohno Y., Sakamoto H., Ishibashi T., Wakabayashi J., Tojima R., et al. Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats. Jpn J Pharmacol 72 (1996) 119-126
33. Ishiyama T., Tokuda K., Ishibashi T., Ito A., Toma S., and Ohno K. Lurasidone (SM-13496), a novel antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. Eur J Pharmacol 572 2-3 (2007) 160-170
34. Johnson F.N. The effects of chlorpromazine on one-trial passive avoidance learning in mice: further examination of pre- and post-learning administration. Psychopharmacologia 18 (1970) 11-18
35. Johnson F.N. The effects of chlorpromazine on the expression of an acquired passive avoidance response in mice. Psychopharmacologia 18 (1970) 333-345
36. Joordens R.J., Hijzen T.H., and Olivier B. The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption. Life Sci 63 (1998) 2227-2232
37. Kapur S., VanderSpek S.C., Brownlee B.A., and Nobrega J. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305 (2003) 1-7
38. Kapur S., VanderSpek S.C., Brownlee B.A., and Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305 (2003) 625-631
39. Karl T., Duffy L., O'Brien E., Matsumoto I., and Dedova I. Behavioural effects of chronic haloperidol and risperidone treatment in rats. Behav Brain Res 171 2 (2006) 286-294
40. Klint T. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats. Behav Pharmacol 2 (1991) 481-489
41. Kovacs G.L., and de Wied D. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity. Eur J Pharmacol 53 (1978) 103-107
42. Li M., Parkes J., Fletcher P.J., and Kapur S. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases. Pharmacol Biochem Behav 78 (2004) 811-819
43. Li M., Fletcher P.J., and Kapur S. Time course of the antipsychotic effect and the underlying behavioral mechanisms. Neuropsychopharmacology 32 (2007) 263-272
44. Majewska M.D. Steroid regulation of the GABAA receptor: ligand binding, chloride transport and behaviour. Ciba Found Symp 153 (1990) 83-97 discussion 97-106
45. Mansbach R.S., Harrod C., Hoffmann S.M., Nader M.A., Lei Z., Witkin J.M., et al. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246 (1988) 114-120
46. Manzaneque J.M., Brain P.F., and Navarro J.F. Effect of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 349-355
47. Marx C.E., VanDoren M.J., Duncan G.E., Lieberman J.A., and Morrow A.L. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28 (2003) 1-13
48. Marx C.E., Shampine L.J., Duncan G.E., VanDoren M.J., Grobin A.C., Massing M.W., et al. Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?. Pharmacol Biochem Behav 84 (2006) 598-608
49. Marx C.E., Shampine L.J., Khisti R.T., Trost W.T., Bradford D.W., Grobin A.C., et al. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions. Pharmacol Biochem Behav 84 (2006) 609-617
50. Masson S., Avanzi V., Troncoso A.C., and Brandao M.L. Effects of apomorphine and clozapine on conditioned freezing and latent inhibition. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 935-943
51. Millan M.J., Audinot V., Melon C., and Newman-Tancredi A. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia. Eur J Pharmacol 280 (1995) 225-229
52. Molewijk H.E., van der Poel A.M., Mos J., van der Heyden J.A., and Olivier B. Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology (Berl) 117 (1995) 32-40
53. Moore N.A., Tye N.C., Axton M.S., and Risius F.C. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262 (1992) 545-551
54. Murphy C.A., and Feldon J. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance. Behav Pharmacol 11 (2000) 307-316
55. Nabeshima T., Tohyama K., Ichihara K., and Kameyama T. Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system. J Pharmacol Exp Ther 255 (1990) 789-794
56. Nissen M.J., Knopman D.S., and Schacter D.L. Neurochemical dissociation of memory systems. Neurology 37 (1987) 789-794
57. Olivier B., Zethof T., Pattij T., van Boogaert M., van Oorschot R., Leahy C., et al. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463 (2003) 117-132
58. Ortega-Alvaro A., Gibert-Rahola J., and Mico J.A. Influence of chronic treatment with olanzapine, clozapine, and scopolamine on performance of a learned 8-arm radial maze task in rats. Prog Neuropsychopharmacol Biol Psychiatry 30 1 (2006) 104-111
59. Papp M. Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning. Eur J Pharmacol 151 (1988) 321-324
60. Ponnusamy R., Nissim H.A., and Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 12 (2005) 399-406
61. Rasmussen T., Fink-Jensen A., Sauerberg P., Swedberg M.D., Thomsen C., Sheardown M.J., et al. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophr Res 49 (2001) 193-201
62. Sachdev P.S., and Saharov T. Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia. Psychiatry Res 81 (1998) 323-332
63. Salmi P., Karlsson T., and Ahlenius S. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat. Eur J Pharmacol 253 (1994) 67-73
64. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety?. Eur J Pharmacol 463 (2003) 133-143
65. Sanger D.J., and Joly D. Anxiolytic drugs and the acquisition of conditioned fear in mice. Psychopharmacology (Berl) 85 (1985) 284-288
66. Shadach E., Feldon J., and Weiner I. Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. Int J Neuropsychopharmcol 2 (1999) 283-291
67. Siemiatkowski M., Maciejak P., Sienkiewicz-Jarosz H., Czlonkowska A.I., Szyndler J., Gryczynska A., et al. Opposite effects of olanzapine and haloperidol in rat ultrasonic vocalization test. Pol J Pharmacol 53 (2001) 669-673
68. Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in Morris Water maze. A comparative study between novel and reference antipsychotics. Psychopharmacol 124 1-2 (1996) 435-440
69. Spealman R.D., and Katz J.L. Some effects of clozapine on punished responding by mice and squirrel monkeys. J Pharmacol Exp Ther 212 (1980) 435-440
70. Taukulis H.K., Fillmore M.T., and Ruggles J.L. Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat. Pharmacol Biochem Behav 41 (1992) 13-21
71. Thiessen D.D., and Upchurch M. Haloperidol and clonidine increase, and apomorphine decreases ultrasonic vocalizations by gerbils. Psychopharmacology (Berl) 75 (1981) 287-290
72. Timmerman W., Tepper P.G., Bohus B.G., and Horn A.S. The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437. Eur J Pharmacol 181 (1990) 253-260
73. Tohyama K., Nabeshima T., Ichihara K., and Kameyama T. Involvement of GABAergic systems in benzodiazepine-induced impairment of passive avoidance learning in mice. Psychopharmacology (Berl) 105 (1991) 22-26
74. Vivian J.A., and Miczek K.A. Diazepam and gepirone selectively attenuate either 20-32 or 32-64 kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology (Berl) 112 (1993) 66-73
75. Wadenberg M.L., and Hicks P.B. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?. Neurosci Biobehav Rev 23 (1999) 851-862
76. Wiley J.L., Compton A.D., and Porter J.H. Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 45 (1993) 263-267
77. Wohr M., Borta A., and Schwarting R.K. Overt behavior and ultrasonic vocalization in a fear conditioning paradigm: a dose-response study in the rat. Neurobiol Learn Mem 84 (2005) 228-240